GMT Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-204,535	Closed	-$5.75M	–	71
2022 Q3	$5.75M	Hold	204,535	–	–	0.36%	48
2022 Q2	$5.51M	Hold	204,535	–	–	0.35%	44
2022 Q1	$6.97M	Buy	+204,535	New	+$6.97M	0.44%	39